Procainamide-induced pulmonary fibrosis after orthotopic heart transplantation: a case report and literature review

Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology
Manoj ThangamIgor D Gregoric

Abstract

A 33-year-old African-American woman was bridged to heart transplantation with a left ventricular assist device. She had a 14-month history of heart failure secondary to viral cardiomyopathy. The patient's refractory ventricular tachycardia was treated with intravenous procainamide owing to the patient's history of amiodarone-induced thyroiditis. After orthotopic cardiac transplant, she experienced prolonged respiratory failure. Serial computed tomography evaluation of the lung revealed diffuse bilateral ground-glass opacities and septal thickening. Bronchoscopies with tissue biopsies were performed with no conclusive results. Specimen samples displayed septal fibrosis with loose fibromyxoid tissue and some hobnail nodularities with no indication of granulomas, neutrophilic infiltration, malignancy, or fungal, viral, or bacterial growth. Histopathological evaluation of the lung wedge biopsy supported a diagnosis of pulmonary fibrosis and noted interstitial fibrosis with areas of focal alveolar hemorrhage and increased macrophage infiltration. Antinuclear body was found to be negative. After in-depth evaluation of the patient's medication history, procainamide was identified as the cause of the toxicity. As procainamide-induced ...Continue Reading

References

Sep 1, 1991·The American Journal of Medicine·S Sheikh, J S Seggev
Jan 1, 1987·Archives of Internal Medicine·J I KennedyJ D Fulmer
Feb 20, 1999·Journal of the American Academy of Dermatology·M E MingL M Cohen
Jan 1, 1957·Circulation·B B BRODIEJ M STEELE
Dec 27, 1962·The New England Journal of Medicine·A T LADD
Apr 6, 2004·Clinics in Chest Medicine·Luc M Delaunois
Mar 16, 2005·Toxicology·Robert L Rubin
Apr 21, 2006·Seminars in Ultrasound, CT, and MR·C Isabela S Silva, Nestor L Müller
Jun 2, 2006·Arthritis and Rheumatism·Belinda BirnbaumClement E Tagoe
Aug 3, 2007·Proceedings of the National Academy of Sciences of the United States of America·Roger D Kornberg
May 20, 2008·Autoimmunity Reviews·Ying Zhou, Qianjin Lu
Jul 27, 2010·Autoimmunity Reviews·Uriel Katz, Gisele Zandman-Goddard
Mar 6, 2012·Biochemical Pharmacology·Fei LiJeffrey R Idle
Sep 28, 2013·Science·Kenji MurakamiRoger D Kornberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Artificial Heart & Ventricular Assist Devices

Total artificial hearts (TAH) and ventricular assist devices (VADs) provide cardiac support for patients with end-stage heart disease and have significantly improved the survival of these patients. Discover the latest research on Artificial Heart and Ventricular Assist Devices here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.